healthandpharma3h
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...
The Pharma Letter3h
The week in pharma: action, reaction and insight – week to October 19
Last week’s significant news included Denmark-based CNS drugmaker Lundbeck reaching agreement to acquire US firm Longboard ...
Roche receives FDA approval for Ventana CLDN18 RxDx Assay
Roche (RHHBY) announced that the VENTANA CLDN18 RxDx Assay is the first U.S. Food and Drug Administration approved ...
devdiscourse14h
Health Sector Headlines: From FDA Approvals to CEO Transitions
Recent health news includes FDA's approval of Astellas' gastric cancer therapy, the resignation of CVS Health CEO Karen Lynch ...
The Pharma Letter23h
FDA approves Astellas’ Vyloy
The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic ...